Prolonged QRS duration in patients with heart failure: Relation to exercise tolerance, diastolic function and aetiology

Kardiologia Polska

Volumn 66, Issue 12, 2008, Pages 1251-1257

  Straburzyńska Migaj, Ewa ^a   Szyszka, Andrzej ^a   Cieśliński, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

BNP; Diastolic function; Heart failure; Peak VO2; Prolonged QRS

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TOLERANCE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OXYGEN CONSUMPTION; PROLONGED QRS DURATION; PROTEIN BLOOD LEVEL; QRS COMPLEX;

EID: 58549103707     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46: 2183-92.
2. Iuliano S, Fisher SG, Karasik PE, et al. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085-91.
3. Kalra PR, Sharma R, Shamim W, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002; 86: 225-31.
4. Bruch C, Stypmann J, Grude M, et al. Left bundle branch block in chronic heart failure - impact on diastolic function, filling pressures, and B-type natriuretic peptide. J Am Soc Echocardiogr 2006; 19: 95-100.
5. Whalley GA, Gamble GD, Doughty RN. The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis. Int J Cardiol 2007; 116: 70-7.
6. Patrianakos AP, Parthenakis FI, Papadimitriou EA, et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur J Heart Fail 2004; 6: 735-43.
7. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.
8. Yu MC, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996; 17: 1694-702.
9. Straburzyńska-Migaj E, Szyszka A, Trojnarska O, et al. Restrictive filling pattern predicts pulmonary hypertension and is associated with increased BNP levels and impaired exercise capacity in patients with heart failure. Kardiol Pol 2007; 65: 1049-55.
10. Krüger S, Graf J, Kunz D, et al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 718-22.
11. De Feo S, Franceschini L, Brighetti G, et al. Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. Int J Cardiol 2005; 104: 292-7.
12. Juilličre Y, Grentzinger A, Houplon P, et al. Role of etiology of cardiomyopathies on exercise capacity and oxygen consumption in patients with severe congestive heart failure. Int J Cardiol 2000; 73: 251-5.
13. Silverman ME, Pressel MD, Brackett JC, et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 1995; 75: 460-4.
14. Straburzyńska-Migaj E, Ochotny R, Chmara E, et al. Angiotensin converting enzyme gene polymorphism in patients with heart failure. Folia Cardiol 2005; 12: 103-10.
15. Straburzyńska-Migaj E, Ochotny R, Straburzyńska-Lupa A, et al. Cytokiny a czynność układu oddechowego i nietolerancja wysiłku w niewydolności serca. Pol Przegl Kard 2005; 7: 129-35.
16. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: V15-16.
17. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
18. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization therapy on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
19. Mancini D, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timinig of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-86.
20. Arena R, Tevald M, Peberdy MA. Influence of etiology on ventilatory expired gas and prognosis in heart failure. Int J Cardiol 2005; 99: 217-23.
21. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-8.
22. Duncan AM, Francis DP, Gibson DG, et al. Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. J Am Coll Cardiol 2004; 43: 1524-31.
23. Hayashida W, Kumada T, Nohara R, et al. Left ventricular regional wall stress in dilated cardiomyopathy. Circulation 1990; 82: 2075-83.
24. Lapu-Bula R, Robert A, De Kock M, et al. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic cardiomyopathy. Am J Cardiol 1999; 83: 728-34.
25. Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a predictor of mortality in chronic heart failure? Int J Cardiol 1999; 70: 171-8.
26. Grines CL, Bashore TM, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation 1989; 79: 845-53.
27. Erlenbacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol 2001; 88: 83-6.
28. Bruch C, Gotzmann M, Stypmann J, et al. Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure. J Am Coll Cardiol 2005; 45: 1072-5.
29. Sutton MGSJ, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985-90.